Patents by Inventor Michael Pinchasov

Michael Pinchasov has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8080672
    Abstract: Provided is a crystal form of atorvastatin hemi-calcium and processes for its preparation.
    Type: Grant
    Filed: December 13, 2006
    Date of Patent: December 20, 2011
    Assignee: Teva Pharmaceutical Industries Ltd.
    Inventors: Michael Pinchasov, Judith Aronhime, Zvika Doani
  • Patent number: 7563918
    Abstract: The present invention relates to solid amorphous and crystalline forms of ibandronate sodium.
    Type: Grant
    Filed: December 22, 2006
    Date of Patent: July 21, 2009
    Assignee: Teva Pharmaceutical Industries Ltd.
    Inventors: Revital Lifshitz-Liron, Thomas Bayer, Judith Aronhime, Michael Pinchasov
  • Patent number: 7511174
    Abstract: Provided are novel crystalline and amorphous forms of ibandronic acid, methods for their preparation, and pharmaceutical compositions containing them. Also provided are methods for purifying and assaying ibandronic acid in any crystalline form (or amorphous).
    Type: Grant
    Filed: September 22, 2006
    Date of Patent: March 31, 2009
    Assignee: Teva Pharmaceutical Industries Ltd
    Inventors: Thomas Bayer, Ben-Zion Dolitzky, Revital Lifshitz-Liron, Inna Perutski, Michael Pinchasov
  • Publication number: 20090069598
    Abstract: Provided are novel crystalline forms of ibandronic acid, physical data, methods for their preparation, and uses therefor. Also provided are methods for purifying and assaying ibandronic acid in any crystalline form.
    Type: Application
    Filed: October 15, 2008
    Publication date: March 12, 2009
    Inventors: Thomas Bayer, Ben-Zion Dolitzky, Revital Lifshitz-Liron, Inna Perutski, Michael Pinchasov
  • Publication number: 20090023949
    Abstract: Amorphous ibandronic acid is provided with methods for its preparation. The methods include dissolution of ibandronic acid in a solvent such as acetonitrile, DMSO, methanol, or water, and spray drying.
    Type: Application
    Filed: July 10, 2008
    Publication date: January 22, 2009
    Inventors: Thomas Bayer, Ben-Zion Dolitzky, Revital Lifshitz-Liron, Inna Perutski, Michael Pinchasov
  • Patent number: 7368606
    Abstract: Provided is amorphous cinacalcet hydrochloride, processes for the preparation thereof, and pharmaceutical compositions therewith.
    Type: Grant
    Filed: May 23, 2006
    Date of Patent: May 6, 2008
    Assignee: Teva Pharmaceutical Industries Ltd.
    Inventors: Revital Lifshitz-Liron, Michael Pinchasov, Shlomit Wizel, Sharon Avhar-Maydan
  • Publication number: 20080027125
    Abstract: Provided are a novel solid states of fluvastatin sodium and processes for preparation thereof.
    Type: Application
    Filed: February 27, 2007
    Publication date: January 31, 2008
    Inventors: Tamas Koltai, Michael Pinchasov, Gustavo Frenkel
  • Publication number: 20070265456
    Abstract: The present invention provides novel forms of atorvastatin designated Forms VI, VIII, IX, X, XI and XII and novel processes for their preparation as well as processes for preparing atorvastatin Forms I, II, IV, V and amorphous atorvastatin. Also provided is atorvastatin hemi-calcium Form VIII that is stable against the formation of atorvastatin hemi-calcium is atorvastatin calcium epoxy dihydroxy (AED).
    Type: Application
    Filed: May 9, 2006
    Publication date: November 15, 2007
    Inventors: Judith Aronhime, Ramy Lidor-Hadas, Valerie Niddam-Hildesheim, Shlomit Wizel, Revital Lifshitz-Liron, Michael Pinchasov
  • Publication number: 20070249845
    Abstract: The present invention encompasses a process for preparing crystalline atorvastatin hemi-calcium characterized by a powder X-ray diffraction pattern having broad peaks in the range of 18.5-21.8 and 21.8-25.0±0.2 degrees two theta.
    Type: Application
    Filed: March 1, 2007
    Publication date: October 25, 2007
    Inventor: Michael Pinchasov
  • Publication number: 20070232683
    Abstract: Provided is a crystal form of atorvastatin hemi-calcium and processes for its preparation.
    Type: Application
    Filed: December 13, 2006
    Publication date: October 4, 2007
    Inventors: Michael Pinchasov, Judith Aronhime, Zvika Doani
  • Publication number: 20070179119
    Abstract: The present invention relates to solid amorphous and crystalline forms of ibandronate sodium.
    Type: Application
    Filed: December 22, 2006
    Publication date: August 2, 2007
    Inventors: Revital Lifshitz-Liron, Thomas Bayer, Judith Aronhime, Michael Pinchasov
  • Publication number: 20070161606
    Abstract: Provided are novel crystalline and amorphous forms of ibandronic acid, methods for their preparation, and pharmaceutical compositions containing them. Also provided are methods for purifying and assaying ibandronic acid in any crystalline form (or amorphous).
    Type: Application
    Filed: September 22, 2006
    Publication date: July 12, 2007
    Inventors: Thomas Bayer, Ben-Zion Dolitzky, Revital Lifshitz-Liron, Inna Perutski, Michael Pinchasov
  • Publication number: 20070112057
    Abstract: Provided are crystalline forms of tegaserod maleate and processes for the preparation thereof.
    Type: Application
    Filed: June 22, 2006
    Publication date: May 17, 2007
    Inventors: Santiago Ini, Tamas Koltai, Michael Pinchasov, Sofia Gorohovsky, Gustavo Frenkel
  • Publication number: 20070054963
    Abstract: Provided is amorphous cinacalcet hydrochloride, processes for the preparation thereof, and pharmaceutical compositions therewith.
    Type: Application
    Filed: May 23, 2006
    Publication date: March 8, 2007
    Inventors: Revital Lifshitz-Liron, Michael Pinchasov, Shlomit Wizel, Sharon Avhar-Maydan
  • Publication number: 20060258633
    Abstract: Provided are amorphous and purely amorphous tegaserod maleate and processes for the preparation thereof. Also provided are pharmaceutical compositions comprising amorphous or purely amorphous tegaserod maleate and methods for the treatment of irritable bowel syndrome using the same.
    Type: Application
    Filed: March 8, 2006
    Publication date: November 16, 2006
    Inventors: Santiago Ini, Michael Pinchasov, Tamas Koltai, Judith Aronhime
  • Publication number: 20060241158
    Abstract: The invention encompasses novel crystalline forms of zolmitriptan herein defined as Form B, D, C, E, F, G, H, I, J, K, M, N, O, P, Q, R, S, or Amorphous and to methods of making thereof. The invention also encompasses methods of making zolmitriptan crystalline Form A.
    Type: Application
    Filed: June 19, 2006
    Publication date: October 26, 2006
    Inventors: Reuven Izsak, Ori Lerman, Tamas Koltai, Judith Aronhime, Michael Pinchasov, Hagit Eisen-Nevo
  • Publication number: 20060241160
    Abstract: The invention encompasses novel crystalline forms of zolmitriptan herein defined as Form B, D, C, E, F, G, H, I, J, K, M, N, O, P, Q, R, S, or Amorphous and to methods of making thereof. The invention also encompasses methods of making zolmitriptan crystalline Form A.
    Type: Application
    Filed: June 19, 2006
    Publication date: October 26, 2006
    Inventors: Reuven Izsak, Ori Lerman, Tamas Koltai, Judith Aronhime, Michael Pinchasov, Hagit Eisen-Nevo
  • Publication number: 20060241159
    Abstract: The invention encompasses novel crystalline forms of zolmitriptan herein defined as Form B, D, C, E, F, G, H, I, J, K, M, N, O, P, Q, R, S, or Amorphous and to methods of making thereof. The invention also encompasses methods of making zolmitriptan crystalline Form A.
    Type: Application
    Filed: June 19, 2006
    Publication date: October 26, 2006
    Inventors: Reuven Izsak, Ori Lerman, Tamas Koltai, Judith Aronhime, Michael Pinchasov, Hagit Eisen-Nevo
  • Publication number: 20060211751
    Abstract: The invention encompasses novel crystalline forms of zolmitriptan herein defined as Form B, D, C, E, F, G, H, I, J, K, M, N, O, P, Q, R, S, or Amorphous and to methods of making thereof. The invention also encompasses methods of making zolmitriptan crystalline Form A.
    Type: Application
    Filed: November 21, 2005
    Publication date: September 21, 2006
    Inventors: Reuven Izsak, Ori Lerman, Tamas Koltai, Judith Aronhime, Michael Pinchasov, Hagit Eisen-Nevo
  • Publication number: 20060106230
    Abstract: Novel processes for the preparation of amorphous atorvastatin hemi-calcium salt are provided, which involve dissolving atorvastatin hemi-calcium salt in certain organic solvents, and removing the solvent such as by spray drying, rapid vacuum evaporation, and/or thin film evaporation. Preferred embodiments of these processes for preparing amorphous atorvastatin hemi-calcium salt are reproducible, applicable on a large scale, and do not involve the use of hydrocarbons.
    Type: Application
    Filed: October 18, 2005
    Publication date: May 18, 2006
    Inventors: Michael Pinchasov, Dalia Maidan-Hanoch